Back

Loss-of-function variants in founder population highlight atrial myopathy as susceptibility to atrial fibrillation

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Mechanisms of atrial and ventricular arrhythmias Genetics, Epigenetics, ncRNA ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Christian Paludan-Muller

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

7 More presentations in this session

Presentation thumbnail
Plasma miR-451a predicts atrial fibrillation recurrence after pulmonary vein ablation
Doctor M. Cebro Marquez (Santiago de Compostela, ES)
Abstract Slides
Presentation thumbnail
Elevated thyroid-stimulating hormone (TSH) is associated with atrial fibrillation and directly modulates electrophysiological properties of atrial cardiomyocytes
Doctor A. Rahm (Heidelberg, DE)
Abstract Slides
Presentation thumbnail
Heterotypic Cx43/Cx45 gap junction channel conductance depends on pulse rate and could rescue from arrhythmogenic activity in cardiac tissue
Doctor K. Maciunas (Edinburgh, GB)
Abstract Slides
Presentation thumbnail
Divergent electrophysiologic safety profile of dapagliflozin and empagliflozin in a whole-heart model
Professor G. Frommeyer (Munster, DE)
Abstract Slides
Presentation thumbnail
Radiation-induced electrophysiological remodelling in neonatal rat ventricular cardiomyocytes
Miss H. Gampp (Heidelberg, DE)
Abstract Slides

Access the full session

Session thumbnail
Mechanisms of atrial and ventricular arrhythmias

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources